Info

Cognia is a next generation database creation and information aggregation company. Cognia's information solutions help pharmaceutical and biotechnology companies cost-effectively accelerate the research and discovery process. Cognia leverages two proprietary synergistic technologies that enable the creation of high quality, expertly curated databases, produced at a frequency never before envisioned. Each database provides a comprehensive collection of the facts about an area of interest to drug target research currently scattered across over 10 million scientific papers. Cognia's ability to produce a new database every two months by the later half of 2007 makes our full offering a must-have strategic information resource to the pharmaceutical and biotechnology industry. The value of our proprietary databases are enhanced by integration with numerous public and third party databases in a common, structured format, placing a broad and deep set of searchable information at the fingertips of researchers around the globe. While most valuable for target identification and validation, the information is also valuable across the range of pre-clinical discovery, including basic research, lead compound generation and optimization. System Biologists and Computational Biologists will also find Cognia's structured information essential. Cognia personnel have extensive experience producing gold standard quality Life Science databases. Our efforts are enhanced by a world-renown Scientific Advisory Board and collaborations with major pharmaceutical companies. Cognia is headquartered in New York, with content and software development operations in Edinburgh Scotland. Cognia's solutions are available by annual subscription license.